5. Dependence models
5.1. Evaluation of tolerance phenomena (opioids, cannabinoids)
5.2. Behavioural determination of the withdrawal syndrome (opioids, cannabinoids, nicotine)
5.3. Withdrawal syndrome-induced conditioned aversion (opioids)
5.4. Spatial conditioning (opioids, cannabinoids, psychostimulants, nicotine)
5.5. Intravenous drug self-administration (cannabinoids, opioids, psychostimulants, nicotine)
5.6. Sensitisation to locomotor effects (opioids, psychostimulants)
5.7. Sensitisation to reinforcing effects (opioids, psychostimulants)